Adma Biologics (ADMA) EBIT (2011 - 2026)
Adma Biologics (ADMA) posted EBIT of $67.76 million for Q3 2026, up 32.8% from $51.01 million a year earlier and up 29.2% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) EBIT (2011 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBIT at Adma Biologics was $241.23 million, up 44.4% year-over-year; for FY2025, it came in at $191.44 million, up 37.7% from FY2024.
- In prior years, Adma Biologics' EBIT was $138.98 million in FY2024 (+542.5%), $21.63 million in FY2023, -$39.37 million in FY2022 and -$58.37 million in FY2021.
- The Q3 2026 figure stands as the highest quarterly EBIT in data going back to Q1 2011.
- On a year-over-year basis, EBIT has increased in each of the last nine quarters, with growth averaging 56.6% over the last eight quarters.
- The year-over-year growth in EBIT has ranged between 9.2% (Q2 2025) and 356.4% (Q3 2024) over the last five years.
- According to Business Quant data, EBIT for the three prior quarters was $52.45 million (Q2 2026), $58.27 million (Q1 2026) and $62.75 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Adma Biologics | 2.87 Bn | 2.39 Bn | 99.92 Mn | 67.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 67.76 Mn |
| Jun 30, 2026 | 52.45 Mn |
| Mar 31, 2026 | 58.27 Mn |
| Dec 31, 2025 | 62.75 Mn |
| Sep 30, 2025 | 51.01 Mn |
| Jun 30, 2025 | 42.80 Mn |
| Mar 31, 2025 | 34.88 Mn |
| Dec 31, 2024 | 38.32 Mn |
| Sep 30, 2024 | 39.64 Mn |
| Jun 30, 2024 | 39.20 Mn |
| Mar 31, 2024 | 21.82 Mn |
| Dec 31, 2023 | 14.23 Mn |
| Sep 30, 2023 | 8.69 Mn |
| Jun 30, 2023 | -473,000.00 |
| Mar 31, 2023 | -813,000.00 |
| Dec 31, 2022 | -6.06 Mn |
| Sep 30, 2022 | -9.32 Mn |
| Jun 30, 2022 | -9.17 Mn |
| Mar 31, 2022 | -14.82 Mn |
| Dec 31, 2021 | -13.19 Mn |
API Access
Adma Biologics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();